|
1
|
Ritter J and Bielack SS: Osteosarcoma. Ann
Oncol. 21(Suppl 7): vii320–vii325. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Steliarova-Foucher E, Stiller C, Lacour B
and Kaatsch P: International Classification of Childhood Cancer,
third edition. Cancer. 103:1457–1467. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fletcher CDM, Unni KK and Mertens F: World
Health Organization Classification of Tumours. Pathology and
Genetics of Tumours of Soft Tissue and Bone. IARC Press; Lyon,
France: pp. 2252002
|
|
4
|
Ottaviani G and Jaffe N: The epidemiology
of osteosarcoma. Cancer Treat Res. 152:3–13. 2009. View Article : Google Scholar
|
|
5
|
Geller DS and Gorlick R: Osteosarcoma: a
review of diagnosis, management, and treatment strategies. Clin Adv
Hematol Oncol. 8:705–718. 2010.PubMed/NCBI
|
|
6
|
Trédan O, Galmarini CM, Patel K and
Tannock IF: Drug resistance and the solid tumor microenvironment. J
Natl Cancer Inst. 99:1441–1454. 2007.
|
|
7
|
Thomlinson RH: Hypoxia and tumours. J Clin
Pathol Suppl. 11:105–113. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Semenza GL and Wang GL: A nuclear factor
induced by hypoxia via de novo protein synthesis binds to the human
erythropoietin gene enhancer at a site required for transcriptional
activation. Mol Cell Biol. 12:5447–5454. 1992.PubMed/NCBI
|
|
9
|
Wang PP, Kong FP, Chen XQ and Du JZ: HIF-1
signal pathway in cellular response to hypoxia. Zhejiang Da Xue Xue
Bao Yi Xue Ban. 40:559–566. 2011.(In Chinese).
|
|
10
|
Carmeliet P, Dor Y, Herbert JM, Fukumura
D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R,
Maxwell P, et al: Role of HIF-1alpha in hypoxia-mediated apoptosis,
cell proliferation and tumour angiogenesis. Nature. 394:485–490.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Piret JP, Mottet D, Raes M and Michiels C:
CoCl2, a chemical inducer of hypoxia-inducible factor-1,
and hypoxia reduce apoptotic cell death in hepatoma cell line
HepG2. Ann NY Acad Sci. 973:443–447. 2002.PubMed/NCBI
|
|
12
|
Goldberg MA and Schneider TJ: Similarities
between the oxygen-sensing mechanisms regulating the expression of
vascular endothelial growth factor and erythropoietin. J Biol Chem.
269:4355–4359. 1994.PubMed/NCBI
|
|
13
|
Brehmer F, Bendix I, Prager S, van de
Looij Y, Reinboth BS, Zimmermanns J, Schlager GW, Brait D,
Sifringer M, Endesfelder S, Sizonenko S, Mallard C, Bührer C,
Felderhoff-Mueser U and Gerstner B: Interaction of inflammation and
hyperoxia in a rat model of neonatal white matter damage. PLoS One.
7:e490232012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar
|
|
15
|
Talks KL, Turley H, Gatter KC, Maxwell PH,
Pugh CW, Ratcliffe PJ and Harris AL: The expression and
distribution of the hypoxia inducible factors HIF-1 alpha and HIF-2
alpha in normal human tissues, cancers and tumor-associated
macrophages. Am J Pathol. 157:411–421. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Covello KL, Simon MC and Keith B: Targeted
replacement of hypoxia-inducible factor-1alpha by a
hypoxia-inducible factor-2alpha knock-in allele promotes tumor
growth. Cancer Res. 65:2277–2286. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pérez-Sayáns M, Suárez-Peñaranda JM, Pilar
GD, Barros-Angueira F, Gándara-Rey JM and García-García A:
Hypoxia-inducible factors in OSCC. Cancer Lett. 313:1–8. 2011.
|
|
18
|
Andrikopoulou E, Zhang X, Sebastian R,
Marti G, Liu L, Milner SM and Harmon JW: Current insights into the
role of HIF-1 in cutaneous wound healing. Curr Mol Med. 11:218–235.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chouaib S, Messai Y, Couve S, Escudier B,
Hasmim M and Noman MZ: Hypoxia promotes tumor growth in linking
angiogenesis to immune escape. Front Immunol. 3:212012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dai S, Huang ML, Hsu CY and Chao KS:
Inhibition of hypoxia inducible factor 1alpha causes
oxygen-independent cytotoxicity and induces p53 independent
apoptosis in glioblastoma cells. Int J Radiat Oncol Biol Phys.
55:1027–1036. 2003. View Article : Google Scholar
|
|
21
|
Xing D, Sun X, Li J, Cui M, Tan-Allen K
and Bonanno JA: Hypoxia preconditioning protects corneal stromal
cells against induced apoptosis. Exp Eye Res. 82:780–787. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Akakura N, Kobayashi M, Horiuchi I, Suzuki
A, Wang J, Chen J, Niizeki H, Kawamura Ki, Hosokawa M and Asaka M:
Constitutive expression of hypoxia-inducible factor-1alpha renders
pancreatic cancer cells resistant to apoptosis induced by hypoxia
and nutrient deprivation. Cancer Res. 61:6548–6554. 2001.
|
|
23
|
Dai ZJ, Gao J, Ma XB, Yan K, Liu XX, Kang
HF, Ji ZZ, Guan HT and Wang XJ: Up-regulation of hypoxia inducible
factor-1α by cobalt chloride correlates with proliferation and
apoptosis in PC-2 cells. J Exp Clin Cancer Res. 31:282012.
|
|
24
|
Ardyanto TD OM, Tokuyasu N, Nagahama Y and
Ito H: CoCl2− induced HIF-1alpha expression
correlates with proliferation and apoptosis in MKN-1 cells: a
possible role for the PI3K/Akt pathway. Int J Oncol. 29:549–555.
2006.
|
|
25
|
Yang SJ, Pyen J, Lee I, Lee H, Kim Y and
Kim T: Cobalt chloride-induced apoptosis and extracellular
signal-regulated protein kinase 1/2 activation in rat C6 glioma
cells. J Biochem Mol Biol. 37:480–486. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Brahimi-Horn C and Pouyssegur J: The role
of the hypoxiainducible factor in tumor metabolism growth and
invasion. Bull Cancer. 93:E73–80. 2006.PubMed/NCBI
|
|
27
|
Cowden Dahl KD, Robertson SE, Weaver VM
and Simon MC: Hypoxia-inducible factor regulates alphavbeta3
integrin cell surface expression. Mol Biol Cell. 16:1901–1912.
2005.PubMed/NCBI
|
|
28
|
Kalpana S, Dhananjay S, Anju B, Lilly G
and Sai Ram M: Cobalt chloride attenuates hypobaric hypoxia induced
vascular leakage in rat brain: molecular mechanisms of action of
cobalt chloride. Toxicol Appl Pharmacol. 231:354–363. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dalerba P, Cho RW and Clarke MF: Cancer
stem cells: models and concepts. Ann Rev Med. 58:267–284. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Clarke MF, Dick JE, Dirks PB, Eaves CJ,
Jamieson CH, Jones DL, Visvader J, Weissman IL and Wahl GM: Cancer
stem cells - perspectives on current status and future directions:
AACR Workshop on cancer stem cells. Cancer Res. 66:9339–9344. 2006.
View Article : Google Scholar
|
|
31
|
Gibbs CP, Kukekov VG, Reith JD,
Tchigrinova O, Suslov ON, Scott EW, Ghivizzani SC, Ignatova TN and
Steindler DA: Stem-like cells in bone sarcomas: implications for
tumorigenesis. Neoplasia. 7:967–976. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fujii H, Honoki K, Tsujiuchi T, Kido A,
Yoshitani K and Takakura Y: Sphere-forming stem-like cell
populations with drug resistance in human sarcoma cell lines. Int J
Oncol. 34:1381–1386. 2009.PubMed/NCBI
|
|
33
|
Borenstein X, Fiszman GL, Blidner A,
Vanzulli SI and Jasnis MA: Functional changes in murine mammary
cancer cells elicited by CoCl2-induced hypoxia. Nitric
Oxide. 23:234–241. 2010. View Article : Google Scholar : PubMed/NCBI
|
